Not an actual patient with Fabry disease.
Not an actual patient with Fabry disease.

Access resources and support for you and your office

Downloadable resources for your practice

Galafold Patient Referral Form

This form serves a dual purpose: as a prescription for Galafold and as a way for patients to register for AMICUS ASSIST.

Download
Galafold Patient Referral Form

This form serves a dual purpose: as a prescription for Galafold and as a way for patients to register for AMICUS ASSIST.

Download
A Quick Guide to Galafold

This flashcard has key, quick-hitting information about Galafold, dosing and administration, and patient support.

Download
A Quick Guide to Galafold

This flashcard has key, quick-hitting information about Galafold, dosing and administration, and patient support.

Download
Volume of Distribution

Learn more about Galafold and its volume of distribution.

Download
Volume of Distribution

Learn more about Galafold and its volume of distribution.

Download
Renal Impact of Fabry Disease

Discover more about the impact Fabry disease has on the kidneys and other organ systems, and how treatment with Galafold may help.

Download
Renal Impact of Fabry Disease

Discover more about the impact Fabry disease has on the kidneys and other organ systems, and how treatment with Galafold may help.

Download
Galafold® MyDay App Postcard

Help your patients establish a dosing regimen with Galafold by using the Galafold® MyDay app. Download this postcard to have on hand to give to your Galafold patients.

Download
Galafold® MyDay App Postcard

Help your patients establish a dosing regimen with Galafold by using the Galafold® MyDay app. Download this postcard to have on hand to give to your Galafold patients.

Download

Visit resources for your practice

Help your patients get support with AMICUS ASSIST®

AMICUS ASSIST is a program designed to provide assistance and support to help eligible patients with Fabry disease and an amenable GLA variant obtain access to Galafold.*

*
Patients must be prescribed Galafold for an approved indication to be eligible for support from AMICUS ASSIST.
Learn more about Fabry disease at FabryFacts.com

Understand more about the complexities of this disease, including signs, symptoms, how diagnosis can vary between genders, and much more.

*
Patients must be prescribed Galafold for an approved indication to be eligible for support from AMICUS ASSIST.
INDICATIONS AND USAGE

Galafold® (migalastat) is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data.

This indication is approved under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

Patient advocacy organizations

FSIG: Fabry Support &
Information Group
National Fabry
Disease Foundation
Genetic Alliance
Rare Disease
Legislative Advocates
NORD: National Organization for Rare Disorders
Global Genes:
Allies in Rare Disease
EveryLife Foundation for Rare Diseases
Fabry International Network

Help your patients with Fabry disease keep moving forward with Galafold

Request a Rep